Arronax Nantes > Expérimentation préclinique et recherche clinique > Nos Publications > Années précédentes > Publications 2014
Publications 2014
- 18F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma. Salaün PY, Campion L, Ansquer C, Frampas E, Mathieu C, Robin P, Bournaud C, Vuillez JP, Taieb D, Rousseau C, Drui D, Mirallié E, Borson-Chazot F, Goldenberg DM, Chatal JF, Barbet J, Kraeber-Bodéré F. (2014) Eur J Nucl Med Mol Imaging. 41, 1501-10.
- A Compartmental Model of Mouse Thrombopoiesis and Erythropoiesis to Predict Bone Marrow Toxicity After Internal Irradiation.Sas N, Rousseau J, Nguyen F, Bellec E, Larrsson E, Becavin S, Hindorf C, Abadie J, Chouin N, Barbet J. (2014) J Nucl Med. 55, 1355-1360.
- Chimeric Antibody c.8B6 to O-Acetyl-GD2 Mediates the Same Efficient Anti-Neuroblastoma Effects as Therapeutic ch14.18 Antibody to GD2 without Antibody Induced Allodynia.Terme M, Dorvillius M, Cochonneau D, Chaumette T, Xiao W, Diccianni MB, Barbet J, Yu AL, Paris F, Sorkin LS, Birklé S. (2014) PLoS One. 9:e87210.